Sign In
Buy ALZN
$1.31
-0.0400 (-2.96%)
At Close: Jul 31, 2026
Alzamend Neuro Earnings Calls
Jul 30, 2026
(Upcoming)
| Release date | Sep 09, 2026 |
| EPS estimate | -$0.670 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 8.93% |
Apr 30, 2026
-$0.740 (-10.45%)
| Release date | Jul 22, 2026 |
| EPS estimate | -$0.670 |
| EPS actual | -$0.740 |
| EPS Surprise | -10.45% |
| Revenue estimate | - |
| Revenue actual | - |
Jan 31, 2026
-$0.580 (-9.43%)
| Release date | Mar 11, 2026 |
| EPS estimate | -$0.530 |
| EPS actual | -$0.580 |
| EPS Surprise | -9.43% |
| Revenue estimate | - |
| Revenue actual | - |
Oct 31, 2025
-$0.300 (63.86%)
| Release date | Dec 09, 2025 |
| EPS estimate | -$0.83 |
| EPS actual | -$0.300 |
| EPS Surprise | 63.86% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Alzamend Neuro
Below you can see how ALZN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Oct 31, 2025
Beat
| Release date | Dec 09, 2025 |
| Price on release | $2.18 |
| EPS estimate | -$0.83 |
| EPS actual | -$0.300 |
| EPS surprise | 63.86% |
| Date | Price |
|---|---|
| Dec 03, 2025 | $2.06 |
| Dec 04, 2025 | $2.15 |
| Dec 05, 2025 | $2.25 |
| Dec 08, 2025 | $2.25 |
| Dec 09, 2025 | $2.18 |
| Dec 10, 2025 | $2.18 |
| Dec 11, 2025 | $2.20 |
| Dec 12, 2025 | $2.17 |
| Dec 15, 2025 | $2.12 |
| 4 days before | 5.83% |
| 4 days after | -2.75% |
| On release day | 0% |
| Change in period | 2.91% |
Jan 31, 2026
Missed
| Release date | Mar 11, 2026 |
| Price on release | $2.18 |
| EPS estimate | -$0.530 |
| EPS actual | -$0.580 |
| EPS surprise | -9.43% |
| Date | Price |
|---|---|
| Mar 05, 2026 | $1.95 |
| Mar 06, 2026 | $1.98 |
| Mar 09, 2026 | $2.10 |
| Mar 10, 2026 | $2.14 |
| Mar 11, 2026 | $2.18 |
| Mar 12, 2026 | $2.09 |
| Mar 13, 2026 | $2.04 |
| Mar 16, 2026 | $2.10 |
| Mar 17, 2026 | $1.86 |
| 4 days before | 11.79% |
| 4 days after | -14.68% |
| On release day | -4.13% |
| Change in period | -4.62% |
Apr 30, 2026
Missed
| Release date | Jul 22, 2026 |
| Price on release | $1.35 |
| EPS estimate | -$0.670 |
| EPS actual | -$0.740 |
| EPS surprise | -10.45% |
| Date | Price |
|---|---|
| Jul 16, 2026 | $1.22 |
| Jul 17, 2026 | $1.21 |
| Jul 20, 2026 | $1.26 |
| Jul 21, 2026 | $1.32 |
| Jul 22, 2026 | $1.35 |
| Jul 23, 2026 | $1.26 |
| Jul 24, 2026 | $1.33 |
| Jul 27, 2026 | $1.34 |
| Jul 28, 2026 | $1.31 |
| 4 days before | 10.66% |
| 4 days after | -2.96% |
| On release day | -6.67% |
| Change in period | 7.38% |
Jul 30, 2026
(Upcoming)
| Release date | Sep 09, 2026 |
| Price on release | - |
| EPS estimate | -$0.670 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 27, 2026 | $1.34 |
| Jul 28, 2026 | $1.31 |
| Jul 29, 2026 | $1.34 |
| Jul 30, 2026 | $1.35 |
| Jul 31, 2026 | $1.31 |
Alzamend Neuro Earnings History
Earnings Calendar
FAQ
When is the earnings report for ALZN?
Alzamend Neuro, Inc. (ALZN) has scheduled its earnings report for Sep 09, 2026 before the markets open.
What is the ALZN price-to-earnings (P/E) ratio?
ALZN P/E ratio as of Jul 31, 2026 (TTM) is -0.466.
What is the ALZN EPS forecast?
The forecasted EPS (Earnings Per Share) for Alzamend Neuro, Inc. (ALZN) for the first fiscal quarter 2026 is -$0.670.
What are Alzamend Neuro, Inc.'s retained earnings?
On its balance sheet, Alzamend Neuro, Inc. reported retained earnings of $0 for the latest quarter ending Apr 30, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
